Personalized Medicine Technology

Frelii, Inc. (OTC: FRLI) Developing personalized medicine using DNA big data & AI | 7/9/2019

… July 9, 2019 admin CEO Interview , Healthcare Comments Off on Frelii, Inc. (OTC: FRLI) Developing personalized medicine using DNA big data & AI Frelii, Inc. (OTC: FRLI), interview with CEO Ian Jenkins discussing the company’s personalized medicine technology which uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome. Ian explains how Frelii is starting to commercialize it’s technology with initial …

Precision Therapeutics Inc. (NASDAQ: AIPT) Secures Lab Status in NIIMBL Drug Safety Grant, Furthers Aim of Improving Medical Care - QualityStocks | 6/3/2019

… a device that facilitates biological fluid collection in the medical arena Helomics was recently selected as the lab of choice for a grant-funded effort to develop test kits for screening prescription drug contaminants Personalized medicine technology developer Precision Therapeutics Inc. (NASDAQ: AIPT) has added a new biomedical research partnership to its portfolio, furthering its mission to apply artificial intelligence to precision medicine and drug discovery in an effort to …

Follow Personalized Medicine Technology:    

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017 | PR Newswire | 10/26/2017

… analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology . These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in …

Global Personalized Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts | PR Newswire | 10/25/2017

… providing easy access to each contract document on demand. Chapter 6 provides a comprehensive and detailed review of Personalized Medicine partnering deals signed and announced since Jan 2010 . The chapter is organized by specific Personalized Medicine technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand. A comprehensive series of …